Siyan Liao Selected Research

Siyan Liao Research Topics

Disease

13	Neoplasms (Cancer) 01/2023 - 01/2012
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2023 - 01/2014
3	Multiple Myeloma 01/2018 - 06/2014
2	Leukemia 01/2018 - 09/2016
2	Rheumatic Fever (Acute Articular Rheumatism) 10/2014 - 07/2014
2	Hepatocellular Carcinoma (Hepatoma) 06/2014 - 01/2012
1	Acute Pain 03/2021
1	Sudden Infant Death (SID) 01/2021
1	Migraine Disorders (Migraine) 01/2021
1	Basal Cell Carcinoma (Rodent Ulcer) 03/2020
1	Diabetes Mellitus 01/2020
1	Hyperbilirubinemia 01/2017
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Breast Neoplasms (Breast Cancer) 11/2014
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2014

Drug/Important Bio-Agent (IBA)

10	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2023 - 01/2012
6	Deubiquitinating EnzymesIBA 01/2023 - 06/2014
4	Imatinib Mesylate (Gleevec)FDA Link 03/2023 - 01/2014
4	Peptide Hydrolases (Proteases)FDA Link 01/2023 - 06/2014
4	Bortezomib (Velcade)FDA Link 07/2014 - 01/2012
3	Proteins (Proteins, Gene)FDA Link 03/2021 - 01/2012
3	Proteasome InhibitorsIBA 01/2018 - 01/2012
3	Antineoplastic Agents (Antineoplastics)IBA 02/2017 - 11/2014
2	CopperIBA 01/2018 - 06/2014
2	Ubiquitinated ProteinsIBA 01/2018 - 01/2017
2	Coordination ComplexesIBA 01/2018 - 06/2014
2	UbiquitinIBA 01/2018 - 06/2014
2	CaspasesIBA 01/2018 - 01/2014
2	GoldIBA 01/2018 - 07/2014
2	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 09/2016
2	DNA (Deoxyribonucleic Acid)IBA 09/2016 - 11/2014
2	Auranofin (Ridaura)FDA Link 10/2014 - 07/2014
2	Antirheumatic Agents (DMARD)IBA 10/2014 - 07/2014
2	gambogic acidIBA 01/2014 - 01/2013
2	Carnitine (L-Carnitine)FDA LinkGeneric 01/2012 - 01/2012
2	Histones (Histone)IBA 01/2012 - 01/2012
2	Histone Deacetylase InhibitorsIBA 01/2012 - 01/2012
1	RutheniumIBA 03/2023
1	piperlongumineIBA 01/2023
1	ArrestinIBA 03/2021
1	mu Opioid Receptors (mu Opioid Receptor)IBA 03/2021
1	Opioid Analgesics (Opioids)IBA 03/2021
1	Analgesics (Analgesic Drugs)IBA 03/2021
1	Morphine (MS Contin)FDA LinkGeneric 03/2021
1	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 01/2021
1	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 01/2021
1	ubrogepantIBA 01/2021
1	rimegepant sulfateIBA 01/2021
1	olcegepantIBA 01/2021
1	HhAntag691IBA 03/2020
1	Smoothened ReceptorIBA 03/2020
1	chiglitazarIBA 01/2020
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	CadmiumIBA 01/2018
1	pyrithioneIBA 01/2018
1	pyrithione zinc (ZPT)FDA Link 02/2017
1	BilirubinIBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	AcidsIBA 01/2017
1	6- amino- 8- ((6- iodo- 1,3- benzodioxol- 5- yl)thio)- N- (1- methylethyl)- 9H-purine-9-propanamineIBA 01/2017
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2017
1	platinum pyrithioneIBA 09/2016
1	ATP dependent 26S protease (26S proteasome)IBA 09/2016
1	Platinum Compounds (Compounds, Platinum)IBA 09/2016
1	PlatinumIBA 09/2016
1	Benzene (Benzole)IBA 06/2014
1	LigandsIBA 06/2014
1	copper pyrithioneIBA 06/2014
1	Disinfectants (Biocides)IBA 06/2014
1	tributyltinIBA 06/2014
1	bcr-abl Fusion ProteinsIBA 01/2014
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 01/2013
1	Adenosine Triphosphate (ATP)IBA 01/2012
1	ChromatinIBA 01/2012
1	Lysine (L-Lysine)FDA Link 01/2012
1	Messenger RNA (mRNA)IBA 01/2012

Therapy/Procedure

6	Therapeutics 01/2018 - 01/2012
1	Intraperitoneal Injections 01/2017